PROFESSIONAL EDITION

The largest community of pharma leaders

Subscribe to Our News!

Admin

5348 articles
Industry News

Immune-Onc Therapeutics Announces First Patient Dosed in Phase 1 Clinical Trial Evaluating IO-108, a Novel Antagonist Antibody Targeting LILRB2 (ILT4), in Patients With Advanced...

Admin -
Look Who’s On the Move!

Former Goldman Sachs VP Jim Johnston Joins Greyledge Technologies as Chief of Corporate Development

Admin -
Industry News

FDA Approves Merck’s KEYTRUDA® (pembrolizumab) Plus Chemotherapy, With or Without Bevacizumab, as Treatment for Patients With Persistent, Recurrent or Metastatic Cervical Cancer Whose Tumors...

Admin -
Industry News

New 4-Year Data Show Genentech’s Enspryng (satralizumab-mwge) Significantly Reduces Debilitating Relapses in People With Neuromyelitis Optica Spectrum Disorder

Admin -
Industry News

Kyowa Kirin International: New Real World Evidence Underlines Benefits of POTELIGEO®▼ (mogamulizumab) Treatment for Cutaneous T-cell Lymphoma (CTCL) Patients

Admin -
Look Who’s On the Move!

Vedanta Biosciences Appoints Simona Levi as Chief Legal Officer and Corporate Secretary

Admin -
Look Who’s On the Move!

 Kojin Therapeutics Announces Luba Greenwood as Chief Executive Officer

Admin -
Look Who’s On the Move!

OnKure Therapeutics Appoints Jennifer R. Diamond, M.D., as Chief Medical Officer

Admin -
123...669Page 1 of 669

Admin

https://magazine.pharmamkt.net

2021 © Copyright - TPMG